Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 347665 | Other Identifier | IRAS ID |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Entia is a health technology company that has developed a blood testing device called Entia Liberty, which analyses blood collected by a finger prick. Entia is sponsoring this research study to compare the results from Entia Liberty finger prick tests to results from the gold-standard laboratory analyser that tests blood from the arm, port, or PICC line.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Phase 1 | Participants who have undergone a laboratory FBC test that has returned a neutrophil count of ≤ 1.0 x109/L who can be consented within 24 hours of the result. Participants will donate one finger prick sample up to once per day to be tested on the Liberty device. |
| |
| Phase 2 | Participants who have undergone a laboratory FBC test that has returned a neutrophil count of ≤ 1.5 x109/L who can be consented within 24 hours of the result. Participants will donate up to 3 finger prick samples to be tested on the Liberty device in a single session. |
| |
| Phase 3 | Participants who are undergoing a routine venous draw as part of the standard of care as part of SACT toxicity monitoring. Participants will donate up to 3 finger prick samples to be tested on the Liberty device in a single session. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Entia Liberty System | Device | Participants will donate finger-prick blood samples to be tested on the Entia Liberty System. The results will not be used to inform clinical decisions or affect routine clinical care in any way. |
| Measure | Description | Time Frame |
|---|---|---|
| Validity of of the Liberty System for haematological parameters of interest: Hb, WBC, PLT, ANC | The accuracy of the Liberty System will be measured by comparing the results of finger-prick blood samples that have been analysed using the Liberty System to the results of venous (blood from the arm, port or PICC line) blood samples that have been analysed by a standard laboratory haematology analyser. | Through study completion, up to 8 days per participant. |
| Reliability of of the Liberty System for haematological parameters of interest: Hb, WBC, PLT, ANC | To measure the precision of the Liberty System by comparing the results of finger-prick blood samples that have been analysed by the Liberty System to each other, and to venous (blood from the arm, port or PICC line) blood samples that have been analysed by the Liberty System. | Through study completion, up to 8 days per participant. |
Not provided
Not provided
Inclusion Criteria:
Additional inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adults with a diagnosis of solid tumour cancer who are undergoing systemic anti-cancer therapy (SACT).
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Hannah Rawlinson-Smith | Contact | 02030200030 | clinical@entia.co | |
| Madeline Lok | Contact | 02030200030 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided